{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "479",
                "487"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "operacji"
        },
        {
            "identifier": "T3",
            "position": [
                "488",
                "595"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzonej z\u0142o\u017conej wady serca pod postaci\u0105 nieprawid\u0142owego odej\u015bcia lewej t\u0119tnicy wie\u0144cowej od pnia pucnego"
        },
        {
            "identifier": "T4",
            "position": [
                "597",
                "623"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "zesp\u00f3\u0142 Bland-Withe-Garland"
        },
        {
            "identifier": "T5",
            "position": [
                "630",
                "662"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "przetrwa\u0142ego przewodu t\u0119tniczego"
        },
        {
            "identifier": "T6",
            "position": [
                "664",
                "680"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "08 i 12.03.2001r"
        },
        {
            "identifier": "T7",
            "position": [
                "817",
                "836"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {},
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "icd": "ICD10:Q25.0",
            "identifier": "N2",
            "referenced": "T5",
            "subtype": "Reference",
            "type": "N",
            "value": "Dro\u00c5\u00bcny przew\u00c3\u00b3d t\u00c4\u0099tniczy"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N3",
            "referenced": "T7",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "arg1": "T6",
            "arg2": "T3",
            "identifier": "R1",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T6",
            "arg2": "T4",
            "identifier": "R2",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T6",
            "arg2": "T5",
            "identifier": "R3",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T6",
            "arg2": "T1",
            "identifier": "R4",
            "subtype": "Dat",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 18 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: m\u0119ska\n------------------------------------------------\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: ICD10:Q24.5|Rozpoznanie II: ICD10:Q25.0|Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: ICD10:Z98.8|Opisowo:: Stan po operacji wrodzonej z\u0142o\u017conej wady serca pod postaci\u0105 nieprawid\u0142owego odej\u015bcia lewej t\u0119tnicy wie\u0144cowej od pnia pucnego (zesp\u00f3\u0142 Bland-Withe-Garland )oraz przetrwa\u0142ego przewodu t\u0119tniczego (08 i 12.03.2001r)\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nCh\u0142opiec z wrodzon\u0105 wad\u0105 serca przyj\u0119ty do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nRKZ Parametry krytyczne\n    pH:7.326\n    pCO2:58.9[mmHg]\n    BE:2.50[mmol/L]\n    HCO3:29.9[mmol/L]\n    pO2:28.1[mmHg]\n    O2Sat:51.3[%]\n    COMMENT_HL7:\nMorfologia\n    WBC:4.76[10\\\\^3/ul]\n    RBC:4.75[10\\\\^6/ul]\n    HGB:14.2[g/dl]\n    HCT:39.7[%]\n    MCV:83.6[fl]\n    MCH:29.9[pg]\n    MCHC:35.8[g/dl]\n    PLT:107.0[10\\\\^3/ul]\n    RDW-SD:38.5[fl]\n    RDW-CV:12.7[%]\n    PDW:12.6[fl]\n    MPV:10.7[fl]\n    P-LCR:32.1[%]\n    PCT:0.1[%]\n    NEUTR#:2.48[10\\\\^3/ul]\n    NEUTR%:52.1[%]\n    LYMPH#:1.87[10\\\\^3/ul]\n    LYMPH%:39.3[%]\n    MONO#:0.31[10\\\\^3/ul]\n    MONO%:6.50[%]\n    EO#:0.07[10\\\\^3/ul]\n    EO%:1.50[%]\n    BASO#:0.03[10\\\\^3/ul]\n    BASO%:0.60[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nImmununochemia -Immulite: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:286.0[ng/ml]\nFibrynogen (F): FIB:2.23[g/L]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:25.5[s]\nINR: INR:1.0\nCzas protrombinowy (PT): PT:11.5[s]\nCzas trombinowy (TT): TT:14.7[s]\nAlbumina w surowicy: ALB -Sur:4.70[g/dl]\nKwas mlekowy: LAC:98.70[mg/dl]\nCK - kinaza kreatynowa: CK:76.00[IU/L]\nGGTP gammaglutamylotranspeptydaza: GGT:14.00[IU/L]\nLDH dehydrogenaza mleczanowa: LDH:299.00[IU/L]\nCholesterol: CHOL:168.00[mg/dl]\nBilirubina ca\u0142kowita TBIL: TBIL:0.60[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:96[%]\nBia\u0142ko ca\u0142kowite: TP:7.60[g/dl]\nKreatynina: CREA:0.80[mg/dl]\nMocznik: UREA:25.00[mg/dl]\nCholesterol LDL (met.bezpo\u015brednia): LDL:99.00[mg/dl]\nCholesterol HDL: HDL:51.00[mg/dl]\nASPAT: AST:33.00[IU/L]\nALAT: ALT:18.00[IU/L]\nNT- proBNP\n    NTpBNP:\n    20.00[pg/ml]\nTroponina T: TnT hs:4.68[pg/ml]\nTSH: TSH:1.44[uIU/ml]\nCK-MB aktywno\u015b\u0107: CK-MBakt.:12.00[IU/L]\nGlukoza w surowicy: GLU-sur:89[mg/dl]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:87.2[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:169[cm]\neGFR (13-18r\u017c M) stand.wg.Schwartza  wsp. 0.700: eGFR13-18M:147.9[ml/min/1,73m2]\nFT3 III: FT3 III:3.19[pg/ml]\nFT4II: FT4II:1.05[ng/dl]\nKwas mlekowy ( osocze ): LAC osocze:26.0[mg/dl]\nImmunochemia - parametry krytyczne: COMMENT_HL7:\n------------------------------------------------\nICD10\n------------------------------------------------\nQ24.5\nQ25.0\nZ98.8\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n89.00\nO69\n89.41\nG21\nG25\n89.541\nL69\n------------------------------------------------"
}